Embed Size (px)
Citation preview
Molecular Diagnostics MDR/MTBELITe MGB® KitReal-Time PCR Assay forTuberculosis and Multidrug Resistance Diagnosis
UNRIVALED SENSITIVITYfor the detectionof Mycobacterium tuberculosis complex
BETTER DIAGNOSISwith simultaneous detection of MTB complex,Rifampicin and Isoniazid resistance
IMPROVED WORKFLOWSample-to-Result Solution
7 MATRICES CE-IVDvalidated for detectionof pulmonary and extrapulmonaryMDR/MTB infections
EMD
MD
R/M
TB E
LITe
MG
B-49
0-20
19/00E
N
Ordering information
Reference
RTS120ING
CTR120ING
CTRCPE
Quantity
48 test
6 test
48 test
Product
MDR/MTB ELITe MGB® Kit
MDR/MTB-ELITe Positive Control
CTRCPE Internal Control
ELITechGroup Molecular Diagnostics, a major innovator in the molecular diagnostic market, o�ers a comprehensive real-time PCR range of products for diagnosis and monitoring of viral and microbiological infections.
“Tuberculosis (TB) is one of the top 10 causes of death worldwide.In 2018, 10 million people fell ill with TB, and 1.5 million died from the disease.Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat. WHO estimates that there were 484 000 new cases with resistance to rifampicin – the most e�ective �rst-line drug, of which 78% had MDR-TB.”
World Health Organization
MDR/MTB ELITe MGB® Kit in combination with ELITe InGenius® system, It o�ers laboratories a complete, sample-to-result and �exible solution for the diagnosis of Mycobacterium tuberculosis complex including �rst-line drug resistant forms in one single-run.
MDR/MTB ELITe MGB® Kit is an ultra-sensitivereal-time PCR assay, designed for the detection ofMTB complex, RIFAMPICIN and ISONIAZID resistance
SENSITIVITY 6 CFU/mlBest on the market
ELITechGroup is certi�ed by DEKRA and applies a quality management system in compliance with ISO 9001:2008 and EN ISO 13485:2012
MDR/MTB ELITe MGB® Kit has been designed to be compliant with WHO guidelines requiring co-detection of Rifampicin and Isoniazid resistance
HeadquartersAustraliaBelgium, LuxemburgBrazilFranceitaly
+33 1 41 45 07 10+61 1800 815 098
+32 9 282 05 31+55 27 3025 1415+33 4 83 36 10 82+39 011 97 61 91
New Zealand SerbiaThe Netherlands UKUnited States
+64 800 555 611+381 11 2467119+31 313 430 500
+44 1442 869 320+1 800 453 2725
WORLDWIDE OFFICESPlease contact your sales representative for terms,conditions and product availability in your country.
“Worldwide, it is estimated that between 10 to 25% of TB infections occur extrapulmonarily, outside of the lungs.”www.tbonline.info
MDR/MTB ELITe MGB® Kit is CE-IVD validated on to allow the detection of bothpulmonarily and extrapulmonarily TB infections7SAMPLE MATRICES
SPUTUMBALCAVITARY FLUIDBRONCHIAL ASPIRATEBIOPSIESURINEGASTRIC ASPIRATES
